You just read:

Kite, a Gilead Company, And Sangamo Therapeutics Announce Collaboration To Develop Next-Generation Engineered Cell Therapies For The Treatment Of Cancer

News provided by

Sangamo Therapeutics, Inc.

Feb 22, 2018, 07:00 ET